Perrigo (PRGO) Scheduled to Post Earnings on Tuesday

Perrigo (NYSE:PRGO) will announce its earnings results before the market opens on Tuesday, May 7th. Analysts expect the company to announce earnings of $0.24 per share for the quarter. Perrigo has set its FY 2024 guidance at 2.500-2.650 EPS and its FY24 guidance at $2.50 to $2.65 EPS.Individual interested in participating in the company’s earnings conference call can do so using this link.

Perrigo (NYSE:PRGO) last posted its earnings results on Tuesday, February 27th. The company reported $0.86 earnings per share for the quarter, beating analysts’ consensus estimates of $0.83 by $0.03. The business had revenue of $1.16 billion for the quarter, compared to analysts’ expectations of $1.17 billion. Perrigo had a negative net margin of 0.27% and a positive return on equity of 7.34%. The firm’s revenue for the quarter was up .1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.75 earnings per share. On average, analysts expect Perrigo to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Perrigo Stock Down 0.8 %

Shares of PRGO opened at $32.79 on Monday. The company has a quick ratio of 1.07, a current ratio of 1.79 and a debt-to-equity ratio of 0.76. The company has a 50-day moving average price of $30.60 and a two-hundred day moving average price of $30.89. The stock has a market cap of $4.44 billion, a price-to-earnings ratio of -327.90 and a beta of 0.63. Perrigo has a 12 month low of $25.77 and a 12 month high of $40.28.

Perrigo Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 18th. Investors of record on Friday, May 31st will be given a dividend of $0.276 per share. The ex-dividend date of this dividend is Friday, May 31st. This represents a $1.10 annualized dividend and a dividend yield of 3.37%. Perrigo’s dividend payout ratio (DPR) is presently -1,100.00%.

Wall Street Analysts Forecast Growth

PRGO has been the topic of a number of analyst reports. JPMorgan Chase & Co. lowered their price target on Perrigo from $48.00 to $41.00 and set an “overweight” rating on the stock in a research report on Wednesday, February 28th. Canaccord Genuity Group reaffirmed a “buy” rating and issued a $42.00 target price on shares of Perrigo in a report on Friday, April 12th. StockNews.com raised shares of Perrigo from a “hold” rating to a “buy” rating in a report on Wednesday, April 3rd. Finally, Piper Sandler boosted their price target on shares of Perrigo from $35.00 to $39.00 and gave the company an “overweight” rating in a research report on Monday, April 8th.

Insider Activity at Perrigo

In other Perrigo news, EVP Robert Willis acquired 6,000 shares of Perrigo stock in a transaction on Thursday, February 29th. The shares were bought at an average price of $25.87 per share, with a total value of $155,220.00. Following the completion of the purchase, the executive vice president now owns 25,105 shares in the company, valued at $649,466.35. The purchase was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In related news, EVP Alison Ives purchased 2,490 shares of the firm’s stock in a transaction dated Tuesday, March 5th. The shares were acquired at an average cost of $27.26 per share, with a total value of $67,877.40. Following the completion of the purchase, the executive vice president now directly owns 16,122 shares of the company’s stock, valued at $439,485.72. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Robert Willis purchased 6,000 shares of the stock in a transaction that occurred on Thursday, February 29th. The stock was bought at an average cost of $25.87 per share, with a total value of $155,220.00. Following the acquisition, the executive vice president now owns 25,105 shares of the company’s stock, valued at $649,466.35. The disclosure for this purchase can be found here. Insiders acquired 17,990 shares of company stock valued at $475,227 in the last three months. Corporate insiders own 0.40% of the company’s stock.

About Perrigo

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.